Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis

Published:2014-09-30 Issue:11 Volume:24 Page:1354-1366
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Dong Yiyu,Van Tine Brian A,Oyama Toshinao,Wang Patricia I,Cheng Emily H,Hsieh James J

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cr2014129.pdf

Reference49 articles.

1. Baselga J . Treatment of HER2-overexpressing breast cancer. Ann Oncol 2010; 21 Suppl 7:vii36–vii40.

2. Olayioye MA, Neve RM, Lane HA, Hynes NE . The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000; 19:3159–3167.

3. Citri A, Yarden Y . EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 2006; 7:505–516.

4. Higgins MJ, Baselga J . Targeted therapies for breast cancer. J Clin Invest 2011; 121:3797–3803.

5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177–182.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1;Pharmacological Research;2024-02

2. TASP1 promotes the proliferation and metastasis of breast cancer by up-regulating ESR1;2024-01-19

3. Disruption of RCAN1.4 expression mediated by YY1/HDAC2 modulates chronic renal allograft interstitial fibrosis;Cell Death Discovery;2023-07-28

4. An updated review on the significance of DNA and protein methyltransferases and de-methylases in human diseases: From molecular mechanism to novel therapeutic approaches;Current Medicinal Chemistry;2023-06-07

5. Combining of immunotherapeutic approaches with chemotherapy for treatment of gastric cancer: Achievements and limitations;International Immunopharmacology;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3